Top Sangamo executive loses control of email account, exposing company secrets

Earlier this year, someone accessed a Sangamo Therapeutics executive’s company email and, for the next 11 weeks, was able to access sensitive and secret information on the company and, potentially, its partners, according to a Tuesday securities filing.

After Sangamo discovered the email…